RecruitingNot ApplicableNCT03890224

Respiratory Support in Chronic Obstructive Pulmonary Disease (COPD) Patients

Respiratory Support in Chronic Obstructive Pulmonary Disease (COPD) Patients After Acute Exacerbation With Monitoring the Quality of Support


Sponsor

Clinact

Enrollment

400 participants

Start Date

Jul 4, 2019

Study Type

INTERVENTIONAL

Conditions

Summary

The hypothesis of this study is that any of 3 modalities of home non- invasive ventilation (NIV) compared to 'no NIV' (=hospital NIV) will reduce re-admission to hospital or death in COPD patients who remain persistently hypercapnic following an exacerbation requiring NIV.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is investigating the best way to support breathing in people with severe COPD (chronic obstructive pulmonary disease) after they have recovered from an episode of breathing failure requiring mechanical ventilation and been taken off the machine. Researchers want to find out whether ongoing home non-invasive ventilation support is beneficial after hospital discharge. **You may be eligible if...** - You have severe COPD with significant airflow obstruction - You were recently hospitalized for a COPD flare-up involving breathing failure that required mechanical ventilation for more than 24 hours - Your breathing and carbon dioxide levels have now stabilized after ventilator removal (stable for 48 hours to 2 weeks) **You may NOT be eligible if...** - You are already on home breathing support devices (NIV or CPAP) - Your breathing problems are primarily caused by obesity, chest wall disease, or non-COPD conditions - You have other serious conditions that prevent participation Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEhome ventilators

The 3 test treatments are home non-targeted NIV, home targeted NIV and rescue home NIV. COPD patients will be equipped with home ventilators and fitted with either nasal, oronasal or facial masks. All the ventilators used will be CE marked.


Locations(1)

Groupe Hospitalier Pitié Salpêtrière-Charles Foix

Paris, Île-de-France Region, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03890224


Related Trials